Literature DB >> 12589817

Immortalization with telomerase of the Nestin-positive cells of the human pancreas.

K M Lee1, C Nguyen, A B Ulrich, P M Pour, M M Ouellette.   

Abstract

Cells expressing the neuronal stem cell marker Nestin are present in the human pancreas but the biological role of these cells has yet to be resolved. We report here the establishment with the catalytic subunit of human telomerase (hTERT) of a line of normal human cells representing this cell type. Primary human cells derived from the ducts of the pancreas were transduced with an hTERT cDNA. The infected cells became positive for telomerase, failed to senesce, and were still proliferating after more than 150 doublings. The immortalized cells were positive for the expression of Nestin (at both the mRNA and protein levels) and were found to be free of cancer-associated changes: diploid and expressing wild type p16(INK4a), p53, and K-Ras. An established line of normal human cells representing this cell type should be of great value to help define the biological properties of this novel cell type.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12589817     DOI: 10.1016/s0006-291x(03)00086-x

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  76 in total

1.  Constitutive K-RasG12D activation of ERK2 specifically regulates 3D invasion of human pancreatic cancer cells via MMP-1.

Authors:  Gregory P Botta; Mauricio J Reginato; Maximilian Reichert; Anil K Rustgi; Peter I Lelkes
Journal:  Mol Cancer Res       Date:  2011-12-08       Impact factor: 5.852

2.  Repression of the miR-143/145 cluster by oncogenic Ras initiates a tumor-promoting feed-forward pathway.

Authors:  Oliver A Kent; Raghu R Chivukula; Michael Mullendore; Erik A Wentzel; Georg Feldmann; Kwang H Lee; Shu Liu; Steven D Leach; Anirban Maitra; Joshua T Mendell
Journal:  Genes Dev       Date:  2010-12-15       Impact factor: 11.361

3.  Use of exogenous hTERT to immortalize primary human cells.

Authors:  Kwang M Lee; Kyung H Choi; Michel M Ouellette
Journal:  Cytotechnology       Date:  2004-06       Impact factor: 2.058

4.  In vitro models of pancreatic cancer for translational oncology research.

Authors:  Georg Feldmann; Sherri Rauenzahn; Anirban Maitra
Journal:  Expert Opin Drug Discov       Date:  2009-04-01       Impact factor: 6.098

5.  Expression of oncogenic K-ras and loss of Smad4 cooperate to induce the expression of EGFR and to promote invasion of immortalized human pancreas ductal cells.

Authors:  Shujie Zhao; Yubao Wang; Lin Cao; Michel M Ouellette; James W Freeman
Journal:  Int J Cancer       Date:  2010-11-01       Impact factor: 7.396

6.  Cyclin-dependent kinase 5 is amplified and overexpressed in pancreatic cancer and activated by mutant K-Ras.

Authors:  John P Eggers; Paul M Grandgenett; Eric C Collisson; Michelle E Lewallen; Jarrod Tremayne; Pankaj K Singh; Benjamin J Swanson; Judy M Andersen; Thomas C Caffrey; Robin R High; Michel Ouellette; Michael A Hollingsworth
Journal:  Clin Cancer Res       Date:  2011-08-08       Impact factor: 12.531

7.  Quantitation of circulating satellite RNAs in pancreatic cancer patients.

Authors:  Takahiro Kishikawa; Motoyuki Otsuka; Takeshi Yoshikawa; Motoko Ohno; Keisuke Yamamoto; Natsuyo Yamamoto; Ai Kotani; Kazuhiko Koike
Journal:  JCI Insight       Date:  2016-06-02

8.  Cross-species analysis of nicotine-induced proteomic alterations in pancreatic cells.

Authors:  Darwin L Conwell; Hanno Steen; Joao A Paulo; Raul Urrutia; Vivek Kadiyala; Peter Banks
Journal:  Proteomics       Date:  2013-05       Impact factor: 3.984

9.  Bmi1 combines with oncogenic KRAS to induce malignant transformation of human pancreatic duct cells in vitro.

Authors:  Shao-Jie Chen; Yin-Ting Chen; Lin-Juan Zeng; Qiu-Bo Zhang; Guo-da Lian; Jia-Jia Li; Ke-Ge Yang; Chu-Mei Huang; Ya-Qing Li; Zhong-Hua Chu; Kai-Hong Huang
Journal:  Tumour Biol       Date:  2016-03-08

10.  Sonic hedgehog promotes desmoplasia in pancreatic cancer.

Authors:  Jennifer M Bailey; Benjamin J Swanson; Tomofumi Hamada; John P Eggers; Pankaj K Singh; Thomas Caffery; Michel M Ouellette; Michael A Hollingsworth
Journal:  Clin Cancer Res       Date:  2008-10-01       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.